Insilico Medicine Overview
Company Headquarters: Hong Kong, China
Founded: 2014
Workforce: 200
Company Working: Insilico Medicine is a technology company specializing in drug discovery and drug development processes. It offers products under the category of pharma.AI suite, pandaomics, chemistry42, and inclinico. The company is dedicated to expanding human productive longevity and transforming every step of the drug discovery and drug development process by best practices in biomarker discovery, drug development, digital medicine, and aging research. The company has a strong business presence in the US, China, Canada, UAE, Belgium, the UK, and Taiwan.
Strategy
Insilico Medicine focuses on providing transforming drug discovery and development with artificial intelligence software, significantly reducing the time and cost to bring life-saving medications to patients. The company continuously focuses on facilitating a precision medicine future while developing an internal pipeline in core therapeutic areas including fibrosis, oncology, immunology, and central nervous system disorders.
